Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pfenex Inc (PFNX)

Pfenex Inc (PFNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Pfenex to Present at the Piper Jaffray 31st Annual Healthcare Conference

Pfenex Inc. (NYSE American: PFNX) is a development and licensing biotechnology company focused on leveraging its PfÄ"nex Expression Technology(R) to develop and improve protein therapies for unmet patient...

PFNX : 10.62 (-2.21%)
Pfenex to Present at the Evercore ISI HealthCONx Conference 2019

Pfenex Inc. (NYSE American: PFNX) is a development and licensing biotechnology company focused on leveraging its PfÄ"nex Expression Technology(R) to develop and improve protein therapies for unmet patient...

PFNX : 10.62 (-2.21%)
Pfenex Announces Management Change

Pfenex Inc. (NYSE American: PFNX), today announced that Susan Knudson has resigned for personal reasons from her role as Senior Vice President, Chief Financial Officer effective November 13, 2019, but...

PFNX : 10.62 (-2.21%)
Pfenex (PFNX) Matches Q3 Earnings Estimates

Pfenex (PFNX) delivered earnings and revenue surprises of 0.00% and 3.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

PFNX : 10.62 (-2.21%)
Pfenex to Present at the Jefferies 2019 London Healthcare Conference

Pfenex Inc. (NYSE American: PFNX) today announced that Eef Schimmelpennink, President and Chief Executive Officer, will be presenting at the Jefferies 2019 London Healthcare Conference on Wednesday, November...

PFNX : 10.62 (-2.21%)
Pfenex (PFNX) Reports Next Week: Wall Street Expects Earnings Growth

Pfenex (PFNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PFNX : 10.62 (-2.21%)
Pfenex to Announce Third Quarter 2019 Financial Results on November 7th

Pfenex Inc. (NYSE American: PFNX), a development and licensing biotechnology company focused on leveraging its PfÄ"nex Expression Technology(R) to develop and improve protein therapies for unmet patient...

PFNX : 10.62 (-2.21%)
Implied Volatility Surging for Pfenex (PFNX) Stock Options

Investors need to pay close attention to Pfenex (PFNX) stock based on the movements in the options market lately.

PFNX : 10.62 (-2.21%)
Shares of Pfenex Inc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (PFNX, VCYT , KPTI , GBT , REGN )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

KPTI : 17.45 (-3.27%)
VCYT : 29.99 (+5.80%)
PFNX : 10.62 (-2.21%)
Watch for Pfenex Inc to Potentially Pullback After Gaining 3.53% Yesterday

Pfenex Inc (AMEX:PFNX) traded in a range yesterday that spanned from a low of $8.47 to a high of $9.03. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $8.86 on...

PFNX : 10.62 (-2.21%)
Biotech Brief: U.S. Medical Technology Market Projected To Exceed $200 Billion By 2023

Medical device manufacturing remains a strong market, driven by technological developments, an aging population, and increases in chronic and lifestyle diseases - trends that expand healthcare spending....

MHMNF : 54.5000 (unch)
SOLY : 11.21 (+5.46%)
AKCA : 17.61 (-4.45%)
LVGO : 26.85 (+0.19%)
PFNX : 10.62 (-2.21%)
GILD : 65.93 (-1.23%)
Pfenex Inc has the Best Relative Performance in the Biotechnology Industry (PFNX, HRTX , NTRA , FLXN , ARWR)

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

HRTX : 25.64 (-3.06%)
NTRA : 36.16 (+4.39%)
PFNX : 10.62 (-2.21%)
ARWR : 65.53 (-1.40%)
2.1% Return Seen to Date on SmarTrend Pfenex Inc Call (PFNX)

SmarTrend identified a Downtrend for Pfenex Inc (AMEX:PFNX) on September 23rd, 2019 at $8.72. In approximately 2 weeks, Pfenex Inc has returned 2.13% as of today's recent price of $8.53.

PFNX : 10.62 (-2.21%)
Thinking about buying stock in Aurora Cannabis, Coca-Cola, Match Group, Pfenex, or RingCentral?

InvestorsObserver issues critical PriceWatch Alerts for ACB, KO, MTCH, PFNX, and RNG.

ACB.TO : 3.21 (-1.53%)
KO : 54.19 (-0.18%)
MTCH : 68.13 (+0.22%)
PFNX : 10.62 (-2.21%)
RNG : 164.91 (-0.02%)
Look for Shares of Pfenex Inc to Potentially Rebound after Yesterday's 8.31% Sell Off

Pfenex Inc (AMEX:PFNX) traded in a range yesterday that spanned from a low of $7.24 to a high of $7.95. Yesterday, the shares fell 8.3%, which took the trading range below the 3-day low of $7.65 on volume...

PFNX : 10.62 (-2.21%)
38.4% Return Seen to Date on SmarTrend Pfenex Inc Call (PFNX)

SmarTrend identified an Uptrend for Pfenex Inc (AMEX:PFNX) on August 13th, 2019 at $7.01. In approximately 1 month, Pfenex Inc has returned 38.37% as of today's recent price of $9.70.

PFNX : 10.62 (-2.21%)
Pfenex to Present at the Cantor Healthcare Conference

Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its PfÄ"nex Expression Technology(R) to improve protein therapies for unmet patient...

PFNX : 10.62 (-2.21%)
Pfenex to Participate in the Oppenheimer Fall Summit

Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its PfÄ"nex Expression Technology(R) to improve protein therapies for unmet patient...

PFNX : 10.62 (-2.21%)
Pfenex Inc is Among the Companies in the Biotechnology Industry with the Best Relative Performance (PFNX, INSM , ALNY , FOLD , ALXN )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

ALNY : 124.23 (+1.84%)
INSM : 22.57 (-3.38%)
PFNX : 10.62 (-2.21%)
Uptrend Call Working As Pfenex Inc Stock Rises 23.1% (PFNX)

SmarTrend identified an Uptrend for Pfenex Inc (AMEX:PFNX) on August 13th, 2019 at $7.01. In approximately 4 weeks, Pfenex Inc has returned 23.11% as of today's recent price of $8.63.

PFNX : 10.62 (-2.21%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.47 , AIZ +1.31 , SBAC +0.58 , SO +0.07 , WELL +0.28
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar